3rd Annual Pharmaceutical Law Conference 2010

Covering:

• Medicines Australia, GMiA and ASMI Codes
• Pharmaceutical Litigation - The Implications of Vioxx
• Challenges around State Procurement Contracts
• Trials and Tribulations of the WADP Price Reduction Regime
• PBS and Pharma - Listing a Drug and Determining the Price
• Enforcement and Compliance for Pharma in Relation to the ACCC
• Pharmaceutical Industry Litigation
• Registration of Biosimilars: Comparison between Australia, Europe and the US
• Case Management and Expert Evidence in Pharmaceutical Patent Cases
• Safety and its Application to Therapeutic Goods
• Generics in Australia after the Memorandum of (Mis) Understanding
• The Complexities of Vaccines
• Application of the Data Exclusivity Regime in Australia
• Retail Pharmacy Sector - Challenges and Opportunities Ahead

MCLE Points: If this particular educational activity is relevant to your immediate or long-term needs in relation to your professional development and practice of the law, then you should claim one "unit" for each hour of attendence, refreshment breaks not included.

Supported by

Media Partners

Online Media Partner